Characterizing drug-induced capillary leak syndromes using the World Health Organization VigiBase.

Philippe Mertz, Bénédicte Lebrun-Vignes, Joe-Elie Salem, Laurent Arnaud

Journal: The Journal of allergy and clinical immunology 2019;143(1):433-436

PMID: 30244023

Full Text on Elsevier Science View on PubMed

Abstract

Address: Service de rhumatologie, Hôpitaux Universitaires de Strasbourg, Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Université de Strasbourg, Strasbourg, France.; AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, Regional Pharmacovigilance Center, Paris, France; INSERM, Paris, France; Sorbonne Universités, Faculty of Medicine, UPMC Univ Paris 06, Paris, France; Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.; Service de rhumatologie, Hôpitaux Universitaires de Strasbourg, Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Université de Strasbourg, Strasbourg, France. Electronic address: [email protected].

DOI: 10.1016/j.jaci.2018.09.001

Link outs

Free resources

Medical:

https://clinicaltrials.gov/search?term=AREA%5BRefe...

Other Literature Sources:

https://scite.ai/reports/30244023

Subscription / membership required

Full Text Sources:

MeSH Terms: Antineoplastic Agents, Capillary Leak Syndrome, Databases, Factual, Humans, Immunologic Factors, Male, Retrospective Studies, World Health Organization